These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 15901795)
1. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. Chen HS; Lipton SA J Pharmacol Exp Ther; 2005 Sep; 314(3):961-71. PubMed ID: 15901795 [TBL] [Abstract][Full Text] [Related]
2. The chemical biology of clinically tolerated NMDA receptor antagonists. Chen HS; Lipton SA J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of memantine. Johnson JW; Kotermanski SE Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266 [TBL] [Abstract][Full Text] [Related]
4. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors. Gilling KE; Jatzke C; Hechenberger M; Parsons CG Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579 [TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL. Grauert M; Rho JM; Subramaniam S; Rogawski MA J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625 [TBL] [Abstract][Full Text] [Related]
6. Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+. Wollmuth LP; Kuner T; Sakmann B J Physiol; 1998 Jan; 506 ( Pt 1)(Pt 1):13-32. PubMed ID: 9481670 [TBL] [Abstract][Full Text] [Related]
7. The selectivity filter of the N-methyl-D-aspartate receptor: a tryptophan residue controls block and permeation of Mg2+. Williams K; Pahk AJ; Kashiwagi K; Masuko T; Nguyen ND; Igarashi K Mol Pharmacol; 1998 May; 53(5):933-41. PubMed ID: 9584221 [TBL] [Abstract][Full Text] [Related]
8. Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker. Parsons CG; Gilling K Methods Mol Biol; 2007; 403():15-36. PubMed ID: 18827985 [TBL] [Abstract][Full Text] [Related]
9. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381 [TBL] [Abstract][Full Text] [Related]
10. Intracellular Mg2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel. Wollmuth LP; Kuner T; Sakmann B J Physiol; 1998 Jan; 506 ( Pt 1)(Pt 1):33-52. PubMed ID: 9481671 [TBL] [Abstract][Full Text] [Related]
11. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Lipton SA Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917 [TBL] [Abstract][Full Text] [Related]
12. Site within N-Methyl-D-aspartate receptor pore modulates channel gating. Chen N; Li B; Murphy TH; Raymond LA Mol Pharmacol; 2004 Jan; 65(1):157-64. PubMed ID: 14722247 [TBL] [Abstract][Full Text] [Related]
13. [Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine]. Kato T Clin Calcium; 2004 Aug; 14(8):76-80. PubMed ID: 15577101 [TBL] [Abstract][Full Text] [Related]
14. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine. Gilling KE; Jatzke C; Parsons CG Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186 [TBL] [Abstract][Full Text] [Related]
15. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Wafford KA; Kathoria M; Bain CJ; Marshall G; Le Bourdellès B; Kemp JA; Whiting PJ Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047 [TBL] [Abstract][Full Text] [Related]
16. Memantine does not show intracellular block of the NMDA receptor channel. Parsons CG; Gilling KE; Jatzke C Eur J Pharmacol; 2008 Jun; 587(1-3):99-103. PubMed ID: 18456253 [TBL] [Abstract][Full Text] [Related]
17. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission. Frizelle PA; Chen PE; Wyllie DJ Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008 [TBL] [Abstract][Full Text] [Related]
18. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063 [TBL] [Abstract][Full Text] [Related]
19. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors. Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657 [TBL] [Abstract][Full Text] [Related]